These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Research progress of gene expression profile of cardiovascular diseases]. Wang RL Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):483-5. PubMed ID: 16134614 [No Abstract] [Full Text] [Related]
3. Molecular signature analysis: using the myocardial transcriptome as a biomarker in cardiovascular disease. Kittleson MM; Hare JM Trends Cardiovasc Med; 2005 May; 15(4):130-8. PubMed ID: 16099376 [TBL] [Abstract][Full Text] [Related]
4. Microarray, SAGE and their applications to cardiovascular diseases. Ye SQ; Lavoie T; Usher DC; Zhang LQ Cell Res; 2002 Jun; 12(2):105-15. PubMed ID: 12118936 [TBL] [Abstract][Full Text] [Related]
13. Design and evaluation of Actichip, a thematic microarray for the study of the actin cytoskeleton. Muller J; Mehlen A; Vetter G; Yatskou M; Muller A; Chalmel F; Poch O; Friederich E; Vallar L BMC Genomics; 2007 Aug; 8():294. PubMed ID: 17727702 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression profiling in cancer from a bioinformatics prospective. Gusev Y; Brackett DJ Expert Rev Mol Diagn; 2007 Nov; 7(6):787-92. PubMed ID: 18020908 [TBL] [Abstract][Full Text] [Related]
16. New gene selection method for multiclass tumor classification by class centroid. Shen Q; Shi WM; Kong W J Biomed Inform; 2009 Feb; 42(1):59-65. PubMed ID: 18835752 [TBL] [Abstract][Full Text] [Related]
17. Physiogenomic strategies and resources to associate genes with rat models of heart, lung and blood disorders. Lee NH Exp Physiol; 2007 Nov; 92(6):992-1002. PubMed ID: 17591683 [TBL] [Abstract][Full Text] [Related]
19. Has gene expression profiling improved diagnosis, classification, and outcome prediction in AML? Willman CL Best Pract Res Clin Haematol; 2008 Mar; 21(1):21-8. PubMed ID: 18342809 [TBL] [Abstract][Full Text] [Related]
20. Reclassification of cardiovascular risk using integrated clinical and molecular biosignatures: Design of and rationale for the Measurement to Understand the Reclassification of Disease of Cabarrus and Kannapolis (MURDOCK) Horizon 1 Cardiovascular Disease Study. Shah SH; Granger CB; Hauser ER; Kraus WE; Sun JL; Pieper K; Nelson CL; Delong ER; Califf RM; Newby LK; Am Heart J; 2010 Sep; 160(3):371-379.e2. PubMed ID: 20826242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]